Dr. Martens (LON:DOCS) Trading Down 10.8% – Time to Sell?

Dr. Martens plc (LON:DOCS)’s stock price was down 10.8% on Thursday . The stock traded as low as GBX 72.30 and last traded at GBX 72.75. Approximately 2,878,701 shares traded hands during trading, an increase of 31% from the average daily volume of 2,195,707 shares. The stock had previously closed at GBX 81.60.

Analyst Upgrades and Downgrades

Separately, Peel Hunt upgraded shares of Dr. Martens to a “buy” rating in a report on Monday, August 18th. One investment analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of GBX 6,000.

Dr. Martens Stock Down 10.2%

The company’s 50 day simple moving average is GBX 90.64 and its 200-day simple moving average is GBX 80.35. The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 127.27. The firm has a market cap of £707.96 million, a P/E ratio of 146.53, a PEG ratio of 6.40 and a beta of 0.11.

Dr. Martens (LON:DOCS) last issued its earnings results on Thursday, November 20th. The company reported GBX (0.90) earnings per share (EPS) for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. Research analysts forecast that Dr. Martens plc will post 2.5809394 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, insider Ije Nwokori sold 298,675 shares of Dr. Martens stock in a transaction on Wednesday, October 15th. The stock was sold at an average price of GBX 90, for a total value of £268,807.50. Also, insider Giles Wilson acquired 105,838 shares of Dr. Martens stock in a transaction that occurred on Monday, September 1st. The shares were purchased at an average price of GBX 91 per share, with a total value of £96,312.58. Over the last 90 days, insiders bought 136,960 shares of company stock worth $12,460,163 and sold 434,460 shares worth $39,131,400. Company insiders own 2.80% of the company’s stock.

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.